Cargando…

COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19

Coronavirus disease 2019 (COVID-19), an infectious disease caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a persistent global threat. The transmission of SARS-CoV-2 is wide and swift. Rapid detection of the viral RNA and effective therapy are imperative to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Yan, Li, Xiang-Ping, Yin, Ji-Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193275/ https://www.ncbi.nlm.nih.gov/pubmed/34131407 http://dx.doi.org/10.7150/ijbs.60655

Ejemplares similares

Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics
por: Chan, Kok Gan, et al.
Publicado: (2021)

CRISPR systems: Novel approaches for detection and combating COVID-19
por: Safari, Fatemeh, et al.
Publicado: (2021)

Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance
por: Duan, Cheng, et al.
Publicado: (2021)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

CRISPR/Cas as a Potential Diagnosis Technique for COVID-19
por: Dara, Mahintaj, et al.
Publicado: (2020)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
por: He, Xuesong, et al.
Publicado: (2022)

How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance
por: Gholizadeh, Pourya, et al.
Publicado: (2020)

The COVID-19 pandemic: one year later – an occupational perspective
Publicado: (2021)

Malignant hemopathy and COVID-19: one year later, lessons from the COVID-19 pandemic
por: Bendari, Mounia
Publicado: (2022)

CRISPR/Cas13: A potential therapeutic option of COVID-19
por: Lotfi, Melika, et al.
Publicado: (2020)

CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
por: Kumar, Prashant, et al.
Publicado: (2020)

Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19
por: Khodavirdipour, Amir, et al.
Publicado: (2021)

CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19
por: Gadwal, A., et al.
Publicado: (2021)

CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
por: Ebrahimi, Saeedeh, et al.
Publicado: (2022)

Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment
por: Zhou, Qianqian, et al.
Publicado: (2022)

CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases
por: Das, Ayan, et al.
Publicado: (2019)

Rational Design of CRISPR/Cas12a-RPA Based One-Pot COVID-19 Detection with Design of Experiments
por: Malcı, Koray, et al.
Publicado: (2022)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens
por: Khambhati, Khushal, et al.
Publicado: (2022)

CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
por: Javed, Muhammad Uzair, et al.
Publicado: (2023)

Medical education in the midst of the coronavirus (COVID-19) pandemic-one year later
por: Alsafi, Zaid, et al.
Publicado: (2021)

One Year Later: What Was the Impact of the COVID-19 Pandemic on Orthopedic Practice?
por: Vasiliadis, Elias, et al.
Publicado: (2021)

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
por: Shi, Yajun, et al.
Publicado: (2023)

COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
por: Fasching, Clare L., et al.
Publicado: (2022)

Potential strategies for combating COVID-19
por: Shamim, Saba, et al.
Publicado: (2020)

Digital solutions to combat Covid-19
Publicado: (2020)

Nanobiotechnology in combating CoVid-19
por: Ganapathy, Dhanraj, et al.
Publicado: (2020)

Enzymatic Catalysts to Combat COVID-19
por: Jhulki, Isita, et al.
Publicado: (2021)

AI in Combating the COVID-19 Pandemic
Publicado: (2022)

CRISPR/Cas9: a double-edged sword when used to combat HIV infection
por: Liang, Chen, et al.
Publicado: (2016)

Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles
por: Wan, Fen, et al.
Publicado: (2021)

CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
por: Osborn, Mark J., et al.
Publicado: (2021)

COVID-19 Pandemic in Lebanon: One Year Later, What Have We Learnt?
por: Koweyes, Jad, et al.
Publicado: (2021)

HALF OF OLDER ADULTS HOSPITALIZED WITH COVID-19 EXPERIENCE SYMPTOMS ONE YEAR LATER
por: Leis, Aleda, et al.
Publicado: (2022)

COVID-19 Combat Fatigue among the Healthcare Workers: The Time for Retrospection and Action
por: Rajhans, Prasad A, et al.
Publicado: (2021)

Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER
por: Wang, Xinjie, et al.
Publicado: (2020)

Application of omics technology to combat the COVID‐19 pandemic
por: Yang, Jingjing, et al.
Publicado: (2021)

COVID-19-Combating English with Chinese Characteristics in the CAT’s Translations
por: Li, Ping, et al.
Publicado: (2022)

Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19
por: Kwon, Sangha, et al.
Publicado: (2021)

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2
por: Hussein, Mouraya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ioe5s6eklqllkrujf55vurldr